Skip to content
Review Open access

Clinical Outcomes of Ivabradine as Adjunctive Therapy in Heart Failure Patients with Left Bundle Branch Block

Oct 2026 · International Journal of Drug Delivery Technology · Vol 16 · 0 citations · 11 references

TL;DR

Ivabradine as adjunctive therapy was associated with improved functional status, better heart rate control, enhanced left ventricular function, and reduced hospitalization among heart failure patients with LBBB.

Abstract

Background Heart failure (HF) with reduced ejection fraction (HFrEF) and left bundle branch block (LBBB) is associated with ventricular dyssynchrony, impaired cardiac function, frequent hospitalizations, and increased mortality. Ivabradine selectively reduces heart rate by inhibiting the If current in the sinoatrial node and has demonstrated clinical benefits in selected HF patients. However, evidence regarding its effectiveness in patients with concomitant LBBB remains limited. Aim To evaluate the clinical outcomes of ivabradine as adjunctive therapy in heart failure patients with left bundle branch block. Methods A retrospective observational study was conducted at VSS Institute of Medical Sciences and Research (VIMSAR), Burla, over 24 months. Medical records of 100 patients with HFrEF and LBBB receiving standard guideline-directed medical therapy (GDMT) were reviewed. Patients were divided into those receiving ivabradine plus GDMT (n=50) and GDMT alone (n=50). Clinical parameters, NYHA functional class, heart rate, left ventricular ejection fraction (LVEF), hospitalization rates, and mortality were compared. Results Patients receiving ivabradine demonstrated significantly greater reduction in resting heart rate (−18.4 ± 6.2 bpm vs −7.1 ± 4.8 bpm, p<0.001), improvement in LVEF (7.6 ± 3.2% vs 3.1 ± 2.5%, p<0.001), and better NYHA class improvement (p=0.002). Heart failure-related hospitalizations were significantly lower in the ivabradine group (18% vs 36%, p=0.041). Mortality was lower in the ivabradine group (8% vs 16%), although the difference did not reach statistical significance (p=0.21). Conclusion Ivabradine as adjunctive therapy was associated with improved functional status, better heart rate control, enhanced left ventricular function, and reduced hospitalization among heart failure patients with LBBB.

Read PDF

Similar papers

Nov 2026

Abstract 8452: Beta-Blocker Therapy and Atrioventricular Conduction Outcomes in Heart Failure with Reduced Ejection Fraction and Fascicular Block

Background: Beta-blockers are a cornerstone of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF). However, their safety in patients with pre-existing fascicular or bundle-branch block remains uncertain because of potential adverse effects on atrioventricular (AV) conduction....

M. Fahim, A. Gorantla, Daoud Eldawud et al. · 0 citations
Open access Oct 2026

PCWP Characterizes Responders of Left Bundle Branch Area Pacing in HFpEF Population.

BACKGROUND The hemodynamic and mechanical benefit of left bundle branch area pacing (LBBAP) in heart failure with preserved ejection fraction (HFpEF) remained underexplored. OBJECTIVES The authors aimed to evaluate the hemodynamic and mechanical response of LBBAP in HFpEF population. METHODS This cohort study inclu...

Yang Su, Xiao-Xiao Xu, Dai-Han Xie et al. · 0 citations
Review Open access Oct 2026

Clinical profile, prognosis, and medical therapy of heart failure with mildly reduced ejection fraction in clinical practice

For 3 of 4 medication classes of guideline-directed medical therapy (GDMT), evidence is poor regarding benefit for those with heart failure with mildly-reduced ejection fraction (HFmrEF; defined as left ventricular ejection fraction 41-49%). Knowledge of how these medications are used in contemporary practice is...

J. Wasfy, E. Shults, S. Gustus et al. · 0 citations
Open access Oct 2026

Empagliflozin and 12-Month Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: A Prospective Observational Cohort Study in Pakistan

In this prospective observational cohort of Pakistani adults with HFpEF, empagliflozin 10 mg once daily added to standard heart failure therapy was associated with a significantly lower hazard of first HF hospitalization, slower deterioration in renal function, and greater improvement in health-related quality of life...

Raffat Sultana, N. Sultana, S. Jaffery et al. · 0 citations
Open access Oct 2026

Impact of Left Bundle Branch Block on Left Ventricular Function in Patients with Heart Failure: A Prospective Observational Study

Background: Left bundle branch block (LBBB) is frequently associated with structural heart disease and heart failure (HF) and is known to cause ventricular dyssynchrony, leading to impaired cardiac function. However, data regarding its impact on left ventricular systolic function in hospitalized HF patients remain limi...

Pappu Bhargava Raghavendra, J. Resident · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.